0000899243-22-003838.txt : 20220201 0000899243-22-003838.hdr.sgml : 20220201 20220201160531 ACCESSION NUMBER: 0000899243-22-003838 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211206 FILED AS OF DATE: 20220201 DATE AS OF CHANGE: 20220201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BELOFF GREGG CENTRAL INDEX KEY: 0001171002 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37566 FILM NUMBER: 22578914 MAIL ADDRESS: STREET 1: C/O CERULEAN PHARMA INC. STREET 2: 840 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNLOGIC, INC. CENTRAL INDEX KEY: 0001527599 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261824804 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET STREET 2: SUITE 402 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-401-9975 MAIL ADDRESS: STREET 1: 301 BINNEY STREET STREET 2: SUITE 402 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Mirna Therapeutics, Inc. DATE OF NAME CHANGE: 20110809 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-12-06 0 0001527599 SYNLOGIC, INC. SYBX 0001171002 BELOFF GREGG C/O SYNLOGIC, INC. 301 BINNEY STREET, SUITE 402 CAMBRIDGE MA 02142 0 1 0 0 See Remarks Stock Option (right to buy) 2.34 2021-12-06 4 A 0 50000 0.00 A 2031-12-06 Common Stock 50000 50000 D The options were issued to the Reporting Person pursuant to the Issuer's 2015 Equity Incentive Award Plan. Such options vest in 12 equal monthly installments starting November 1, 2021, provided the Reporting Person continues to provide services to the Issuer. An aggregate of 50% of the options shall vest immediately if the Issuer terminates the Reporting Person's services before May 1, 2022. Interim Chief Financial Officer /s/ Gregg Beloff 2022-02-01